New York A 4161: Requires written notification where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another

Status: REFERRED TO HIGHER EDUCATION (as of 2018-01-03)

State: New York · Session: 2017-2018 · Bill: A 4161

Sponsors: ROSENTHAL L

View New York A 4161 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.